MIDAZOLAM INJECTION USP
MIDAZOLAM INJECTION USP
Approved
DIN Number
02382377
Drug Class
Human
Market Date
Jun 15, 2016
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02382377
AIG Number0119935002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD08 MIDAZOLAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIDAZOLAMActive
Strength: 1 MG / ML
Monograph: MIDAZOLAM